Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Lexeo Therapeutics (LXEO) Other Gross PP&E Adjustments (2022 - 2026)

Lexeo Therapeutics' Other Gross PP&E Adjustments history spans 2 years, with the latest figure at -$1.4 million for Q4 2023.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 86.24% to -$1.4 million in Q4 2023 year-over-year; TTM through Dec 2023 was -$1.4 million, a 86.24% increase, with the full-year FY2023 number at -$1.4 million, up 86.24% from a year prior.
  • Other Gross PP&E Adjustments hit -$1.4 million in Q4 2023 for Lexeo Therapeutics, up from -$2.0 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for LXEO hit a ceiling of -$1.4 million in Q4 2023 and a floor of -$10.2 million in Q4 2022.